These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3978667)

  • 1. Effects of elevated extracellular potassium concentrations on the class III antiarrhythmic action of sotalol.
    Cobbe SM; Manley BS
    Cardiovasc Res; 1985 Feb; 19(2):69-75. PubMed ID: 3978667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of the rise in extracellular potassium concentration during myocardial ischaemia by d.l-sotalol and d-sotalol.
    Hicks MN; Cobbe SM
    Cardiovasc Res; 1990 May; 24(5):404-10. PubMed ID: 2372795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subsidiary class III effects of beta blockers? A comparison of atenolol, metoprolol, nadolol, oxprenolol and sotalol.
    Manley BS; Alexopoulos D; Robinson GJ; Cobbe SM
    Cardiovasc Res; 1986 Oct; 20(10):705-9. PubMed ID: 2878723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the effects of hypoxia, substrate depletion, acidosis and hyperkalaemia on the class III antiarrhythmic properties of sotalol.
    Cobbe SM; Manley BS; Alexopoulos D
    Cardiovasc Res; 1985 Nov; 19(11):668-73. PubMed ID: 4075356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential rate and potassium-dependent effects of the class III agents d-sotalol and dofetilide on guinea pig papillary muscle.
    Marschang H; Beyer T; Karolyi L; Kübler W; Brachmann J
    Cardiovasc Drugs Ther; 1998 Dec; 12(6):573-83. PubMed ID: 10410827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
    Nakaya H; Tohse N; Takeda Y; Kanno M
    Br J Pharmacol; 1993 May; 109(1):157-63. PubMed ID: 7684298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of acute myocardial ischaemia on the class III antiarrhythmic action of sotalol.
    Cobbe SM; Manley BS; Alexopoulos D
    Cardiovasc Res; 1985 Nov; 19(11):661-7. PubMed ID: 4075355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia.
    MacKenzie I; Saville VL; Waterfall JF
    Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro.
    Kovács A; Gyönös I; Magyar J; Bányász T; Nánási PP; Spedding M; Szénási G
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):78-88. PubMed ID: 11152377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits.
    Baczkó I; El-Reyani NE; Farkas A; Virág L; Iost N; Leprán I; Mátyus P; Varró A; Papp JG
    Eur J Pharmacol; 2000 Sep; 404(1-2):181-90. PubMed ID: 10980278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol.
    Fiset C; Drolet B; Hamelin BA; Turgeon J
    J Pharmacol Exp Ther; 1997 Oct; 283(1):148-56. PubMed ID: 9336319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of electrophysiological mechanisms of anti-arrhythmia III class agents, cardiocyclide, nibentan, and sotalol during experimental myocardial infarction and sympathetic stimulation].
    Kaverina NV; Lyskovtsev VV; Popova EP
    Eksp Klin Farmakol; 2003; 66(1):27-33. PubMed ID: 12683077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic blocking property of dl-sotalol maintains class III efficacy in guinea pig ventricular muscle after isoproterenol.
    Groh WJ; Gibson KJ; McAnulty JH; Maylie JG
    Circulation; 1995 Jan; 91(2):262-4. PubMed ID: 7805226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological characterization of the class III activity of sotalol and its enantiomers. New interpretation of use-dependent effects.
    Hafner D; Berger F; Borchard U; Kullmann A; Scherlitz A
    Arzneimittelforschung; 1988 Feb; 38(2):231-6. PubMed ID: 3370070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of MDL 11,939 on action potential and contractile force in cardiac tissues: a comparison with bretylium, clofilium, and sotalol.
    Li T; Carr AA; Dage RC
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):917-23. PubMed ID: 1704984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class III antiarrhythmic drugs (amiodarone, bretylium and sotalol) on action potentials and membrane currents in rabbit sino-atrial node preparations.
    Satoh H
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):674-81. PubMed ID: 1775200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electromechanical action of dofetilide and D-sotalol during simulated metabolic acidosis in isolated guinea pig ventricular muscle.
    Yang T; Tande PM; Refsum H
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):889-94. PubMed ID: 1282590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGIS-7229, the new combined class III antiarrhythmic agent: lack of EAD inducing effect.
    Bányász T; Magyar J; Varró A; Kovács A; Gyönös I; Szénási G; Nánási PP
    Gen Pharmacol; 1999 Mar; 32(3):329-33. PubMed ID: 10211587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of the new class III antiarrhythmic agents almokalant, E-4031 and D-sotalol, and of quinidine, on delayed rectifier currents in guinea pig ventricular myocytes.
    Wettwer E; Grundke M; Ravens U
    Cardiovasc Res; 1992 Nov; 26(11):1145-52. PubMed ID: 1291093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.